T cell unresponsiveness in vitro can be due to activation in vivo

International Immunology

Volumn 10, Issue 3, 1998, Pages 365-369

  Koniaras, Christina ^a   Heath, William R ^a   Lew, Andrew M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cytotoxic T lymphocyte; Ovalbumin; Peptide; TCR transgenic mice; Tolerance

Indexed keywords

CD8 ANTIGEN; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031937408     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.3.365     Document Type: Article

References (24)

1. Gaur, A., Wiers, B., Liu, A., Rothbard J. and Fathman, C. G. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
2. Friedman, A. and Weiner, H. L. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl Acad. Sci. USA 91:6688.
3. Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M. and Hafler, D. A. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321.
4. Zhang, Z. J., Davidson, L., Eisenbarth, G. and Weiner, H. L. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl Acad. Sci. USA 88:10252.
5. Trentham, D. E., Dynesius, T. R., Orav, E. J., Combitchi, D., Lorenzo, C., Sewell, K. L., Hafler, D. A. and Weiner, H. L. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727.
6. Khare, S. D., Krco, C. J., Griffiths, M. M., Luthra, H. S. and David, C. S. 1995. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 155:3653.
7. Kaufman, D. L., Clare, S. M., Tian, J., Forsthuber, T., Ting, G. S., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J. and Lehmann, P. V. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
8. Tisch, R., Yang, X. D., Liblau, R. S. and McDevitt, H. O. 1994. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J. Autoimmun. 7:845.
9. Aichele, P., Kyburz, D., Ohashi, P. S., Odermatt, B., Zinkernagel, R. M., Hengartner, H. and Pircher, H. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl Acad. Sci. USA 91:444.
10. Kuzu, H., Kuzu, Y., Zaghouani, H. and Bona, C. 1993. In vivo priming effect during various stages of ontogeny of an influenza A virus nucleoprotein peptide. Eur. J. Immunol. 23:1397.
11. Kyburz, D., Aichele, P., Speiser, D. E., Hengartner, H., Zinkernagel, R. M. and Pircher, H. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
12. Aichele, P., Brduscha, R. K., Zinkernagel, R. M., Hengartner, H. and Pircher, H. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182:261.
13. Mamalaki, C., Norton, T., Tanaka, Y., Townsend, A. R., Chandler, P., Simpson, E. and Kioussis, D. 1992. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc. Natl Acad. Sci. USA 89:11342.
14. Liblau, R. S., Tisch, R., Shokat, K., Yang, X., Dumont, N., Goodnow, C. C. and McDevitt, H. O. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc. Natl Acad. Sci. USA 93:3031.
15. Duarte, E.A., Eberl, G. and Corradin, G. 1996. Specific tolerization of active cytolytic T lymphocyte responses in vivo with soluble peptides. Cell. Immunol. 169:16.
16. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
17. Koniaras, C., Bennett, S. R. M., Carbone, F. R., Heath, W. R. and Lew, A. M. 1997. Peptide induced deletion of CDS T cells in vivo occurs via apoptosis in situ. Int. Immunol. 10:1601.
18. Moore, M. W., Carbone, F. R. and Bevan, M. J. 1988 Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
19. Lombardi, G., Sidhu, S., Batchelor, R. and Lechler, R. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.
20. Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M. and June, C. H. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86:1333.
21. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555
22. Rock, K. L., Rothstein, L., Fleischacker, C. and Gamble, S. 1992. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen. J. Immunol. 148:3028.
23. Odermatt, B., Eppler, M., Leist, T. P., Hengartner, H. and Zinkernagel, R. M. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl Acad. Sci. USA 88:8252.
24. Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M. and Feldmann, M. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434.